Advancements of prodrug technologies for enhanced drug selectivity in pharmacotherapies

Invest New Drugs. 2024 Oct;42(5):590-600. doi: 10.1007/s10637-024-01460-0. Epub 2024 Aug 13.

Abstract

The therapeutic effects of many pharmacotherapies have been explored, but disadvantages such as low drug specificity, drug resistance and side effects makes their effective delivery to target sites a great challenge. Consequently, a distinctive prodrug-based technology have emerged as an effective treatments because of their distinctive advantages, such as high drug loading capacity, precise targeting, reduced side effects and spatial and temporal controllability. In particular, the use of gamma/X-ray-mediated strategies in radiotherapy is a new strategy that could enable the precise drug release from implanted devices. This review presents readers with the current state of prodrug therapy and reports the design protocols of rational and effective prodrugs for clinical use.

Keywords: Anticancer; Chemotherapy; Photopharmacology; Prodrugs; Radiopharmacology; Sonopharmacology.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems
  • Humans
  • Prodrugs* / therapeutic use

Substances

  • Prodrugs